March-In Rights Imperatives
$175
About the Course
Has your institution received government funding? Is government funding behind your patents?
Are you licensing patents that were developed with government support?
If so, you really should listen to this informative webinar.
Your rights and economic interests could be dramatically impacted by March-In Rights.
This session discusses the history of March-In Rights as well as current proposals regarding March-In Rights. The following are among the issues discussed during this timely webinar:
- •Who can initiate March-In Rights, and what criteria must be met?
- •Whether agencies must include decision-makers representing different political viewpoints
- •The role of pricing and product availability in March-In determinations
- •Appeal rights, procedures, and filing deadlines
- •Whether unmarked Bayh-Dole–funded patents remain susceptible to March-In
- •How patentees can partially inoculate themselves against March-In risks
- •Compensation rights when March-In is imposed
- •How March-In differs from eminent domain and compulsory licensing
- •Waivers for non-compliance with domestic manufacturing requirements
- •Determining when emergency-triggered March-In rights expire
Course Leader
Ryan C. Smith, Ph.D.
Partner, Duane Morris LLP
Dr. Smith practices in patent law with extensive experience in IP due diligence and U.S. and international patent prosecution in biotechnology and chemical arts. His practice includes non-infringement, invalidity, and freedom-to-operate analyses, as well as IP due diligence for mergers, acquisitions, public offerings, and private equity investments.
His patent strategies have protected several innovative multimillion-dollar drugs including Solosec® and Xiflam™. He works closely with entrepreneurs, emerging growth companies, university technology transfer offices, and large multinational organizations.
Prior to practicing law, Dr. Smith was a research scientist at GE Healthcare and Illumina, where he invented patents fundamental to modern DNA sequencing methods.
He also held postdoctoral fellowships at Stanford University and the IBM Almaden Research Center.
Dr. Smith earned his J.D. from the University of San Diego School of Law, a Ph.D. in Chemistry from the University of California, Berkeley, and a B.S. in Chemistry from the University of California, San Diego.